Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jcin.2022.12.014 | DOI Listing |
EuroIntervention
November 2024
Department of Cardiac Surgery, Medical University Pisa, Pisa, Italy.
EuroIntervention
July 2024
Department of Cardiovascular & Thoracic Surgery, West Virginia University, Morgantown, WV, USA.
Background: Transcatheter mitral valve replacement (TMVR) is a therapeutic option for patients with severe mitral regurgitation (MR) who are ineligible for conventional surgery. There are limited data on the outcomes of large patient cohorts treated with TMVR.
Aims: This study aimed to investigate the outcomes and predictors of mortality for patients treated with transapical TMVR.
J Cardiothorac Surg
January 2024
Department of Cardiology, School of Medicine, Tehran Heart Center, Tehran University of Medical Sciences, North Kargar Street, Tehran, Iran.
We present a patient with a history of heart failure and metallic aortic and mitral valves surgeries, who required ablation for a drug-refractory left ventricular tachycardia. But the metallic valves prohibited the insertion of catheters via retrograde or via trans-septal approaches. Therefore, we decided to perform catheter ablation by direct left ventricle puncture through a minithoracotomy.
View Article and Find Full Text PDFJACC Case Rep
December 2023
Medizinische Klinik und Poliklinik I, LMU Klinikum, LMU München, Munich, Germany.
Residual and recurrent mitral regurgitation after transcatheter edge-to-edge repair are therapeutically challenging. In the present case report, we describe a simplified, transapical electrosurgical laceration and stabilization of clip procedure that represents an alternative and direct approach for electrosurgical laceration of mitral valve leaflets enabling transcatheter mitral valve replacement for recurrent mitral regurgitation after mitral valve transcatheter edge-to-edge repair.
View Article and Find Full Text PDFEur Heart J Case Rep
December 2023
Department of Cardiac Surgery, Medical University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria.
Background: Failing bioprosthesis is an emerging issue due to (i) a shift towards liberal bioprosthesis implantation instead of mechanical prosthesis and (ii) an ageing population. Management of high-risk patients with bioprosthesis degeneration remains challenging.
Case Summary: An 82-year-old patient with history of aortic and mitral valve replacement six years before presents with severe dyspnoea.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!